Published 8 days ago • loading... • Updated 8 days ago

Jubilant Reports Early Platelet Reductions With JBI-802

YARDLEY, PA — Jubilant Therapeutics reported early clinical activity for JBI-802 in a Phase 1/2 trial of patients with myeloproliferative neoplasms, with dose-responsive platelet reductions observed across several disease subtypes …

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

MyChesCo

Jubilant Reports Early Platelet Reductions With JBI-802

8 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated8 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MyChesCo broke the news 8 days ago on Wednesday, September 23, 2026.

Sources are mostly out of (0)

Jubilant Reports Early Platelet Reductions With JBI-802

1 Articles

1 Articles

Jubilant Reports Early Platelet Reductions With JBI-802

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

FTC opens probe into AI giants including Anthropic and OpenAI

U.K. believes Iran "played a part" in incident near RAF Fairford base used by U.S. forces, prime minister says

US removes Syria from arms export ban as Trump administration draws closer to new Syrian government

Bill to limit stock trading in US Congress blocked in Senate

Watchdog finds deficiencies but no Fed misconduct in Powell-era renovation project

UK-France deal aimed at reducing number of migrants crossing Channel in small boats is scrapped

Similar News Topics

Similar News Topics

More stories like this

FTC opens probe into AI giants including Anthropic and OpenAI

U.K. believes Iran "played a part" in incident near RAF Fairford base used by U.S. forces, prime minister says

US removes Syria from arms export ban as Trump administration draws closer to new Syrian government

Bill to limit stock trading in US Congress blocked in Senate

Watchdog finds deficiencies but no Fed misconduct in Powell-era renovation project

UK-France deal aimed at reducing number of migrants crossing Channel in small boats is scrapped

Jubilant Reports Early Platelet Reductions With JBI-802

1 Articles

1 Articles

Jubilant Reports Early Platelet Reductions With JBI-802

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

FTC opens probe into AI giants including Anthropic and OpenAI

U.K. believes Iran "played a part" in incident near RAF Fairford base used by U.S. forces, prime minister says

US removes Syria from arms export ban as Trump administration draws closer to new Syrian government

Bill to limit stock trading in US Congress blocked in Senate

Watchdog finds deficiencies but no Fed misconduct in Powell-era renovation project

UK-France deal aimed at reducing number of migrants crossing Channel in small boats is scrapped

Similar News Topics

Similar News Topics

More stories like this

FTC opens probe into AI giants including Anthropic and OpenAI

U.K. believes Iran "played a part" in incident near RAF Fairford base used by U.S. forces, prime minister says

US removes Syria from arms export ban as Trump administration draws closer to new Syrian government

Bill to limit stock trading in US Congress blocked in Senate

Watchdog finds deficiencies but no Fed misconduct in Powell-era renovation project

UK-France deal aimed at reducing number of migrants crossing Channel in small boats is scrapped

Bias Distribution

Factuality